MFM
MHR Fund Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.8M | Buy |
28,967,103
+4,550,000
| +19% | +$7.83M | 5.53% | 5 |
|
|
2025
Q1 | $81.3M | Hold |
24,417,103
| – | – | 9.77% | 4 |
|
|
2024
Q4 | $181M | Buy |
24,417,103
+420,000
| +2% | +$3.11M | 19.98% | 2 |
|
|
2024
Q3 | $225M | Hold |
23,997,103
| – | – | 24.57% | 2 |
|
|
2024
Q2 | $192M | Hold |
23,997,103
| – | – | 23.45% | 1 |
|
|
2024
Q1 | $356M | Buy |
23,997,103
+4,000,000
| +20% | +$59.3M | 34.36% | 1 |
|
|
2023
Q4 | $163M | Hold |
19,997,103
| – | – | 17.76% | 3 |
|
|
2023
Q3 | $91M | Buy |
19,997,103
+8,000,000
| +67% | +$36.4M | 11.15% | 5 |
|
|
2023
Q2 | $84.5M | Hold |
11,997,103
| – | – | 11.88% | 5 |
|
|
2023
Q1 | $73.3M | Hold |
11,997,103
| – | – | 9.86% | 5 |
|
|
2022
Q4 | $76.7M | Buy |
+11,997,103
| New | +$76.7M | 13.08% | 5 |
|